suMMARY The methods ofdiagnosis (dark ground microscopy and serology), treatment, and follow up of 946 patients with primary and 854 with secondary syphilis who presented to a London STD clinic between 1965 and 1984 were reviewed retrospectively. On dark ground microscopy spirochaetes typical of Treponema pallidum were seen in 673 (78%) of 884 patients with primary syphilitic chancres. Of the patients with primary syphilis, 137 (14.5%) had negative serology results at presentation. Eight (0.9%) of the patients with secondary syphilis had negative results at presentation, but seven of these gave positive results one month later. Procaine penicillin was the treatment used most, and erythromycin the commonest alternative. The Jarisch-Herxheimer reaction occurred more often after treatment with penicillin than with erythromycin or tetracycline (p < 0.005). In most patients the Venereal Diseases Research Laboratory (VDRL) test showed a consistent fall in titre after treatment; a small proportion, however, continued to give positive results (some at a high titre) with no other evidence of reinfection or treatment failure.
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In the first two parts of this study we 
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In patients with primary syphilis 78% (673/864) of the chancres were found to be dark ground positive. Reasons for false negative results include recent local 1% 1% 1% %. 1% e e JP dp df 01 1% 1% % 1% % e e 40 JP JP p 1% 1% 1% 1% 1%
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.JP.o dp .4, d' j dp dp JP JP .0 o JP de dp dp dp j 1 % % % % % JP dp JP de JP j . treatments, recent systemic antibiotic treatment, or excess debris obscuring the view.5 Suggestions have been made that false positive results may be obtained from oral or anal lesions because of the presence of saprophytic spirochaetes. 6 We were unable to find any significant correlation between the site of the lesion and the results of dark field microscopy which contradicts that suggestion.
In patients with primary syphilis the FTA-ABS test is usually the first to give positive results, and the TPHA does so a few weeks later.7 This was confirmed by our study, which showed that 92% of patients had positive results in the FTA-ABS test and 75% in the TPHA at the time ofpresentation. Our finding of 15% of patients giving negative results in all tests at presentation was similar to that reported previously.8
It is generally accepted that all patients with secondary syphilis have positive serological markers at presentation."'0 In our patients eight initially gave negative results, although seven gave positive results one month later. The accuracy of the diagnosis in the one who did not seroconvert is doubtful. In this connection the report of a patient with secondary syphilis and coexisting human immunodeficiency virus (HIV) infection is of some interest." The results of serological tests were initially negative, but became positive 20 days after presentation, and the authors postulated that HIV had altered the serological response to syphilis. Our study suggests that patients with secondary syphilis occasionally give negative serological test results at presentation. Though the HIV status of our patients is not known, at least some of them were diagnosed before advent of HIV infection.
The observation that the Jarish-Herxheimer reaction was more common in patients treated with penicillin possibly reflects a more rapid treponemocidal effect of penicillin compared with tetracycline or erythromycin. Erythromycin and tetracycline are bacteriostatic, rather than bacteriocidal; they inhibit the metabolic processes of the organisms, which allows the host defence mechanisms to kill the treponemes. '2 This may result in a slower release of toxic substances into the bloodstream, and hence a reduced incidence of Jarisch-Herxheimer reactions.
Anderson, Mindel, Tovey, Williams The serological response after treatment has been used as a yardstick to assess its efficacy.'3 In our study 15% of the patients with primary and 29% with secondary syphilis still had positive VDRL test results 13 to 18 months after treatment. No other evidence in these patients suggested treatment failure. In a series of 588 patients with primary and 623 with secondary syphilis Fiumara found complete resolution of symptoms and negative serology test results within one year of treatment in primary and within two years of secondary disease.'4 All the patients had received benzathine penicillin 2.4 MU a week intramuscularly for two weeks or tetracycline 500 mg qds for 12 days. In contrast, other workers have found that up to 3% of patients with primary and 24% of those with secondary syphilis still had positive results in the VDRL two years after treatment. 5 16 It has been suggested that the higher the initial serological titres the longer the time to return to negative results, and it has been shown that those who have been reinfected have been shown to take longer to give negative results than patients with a first episode of primary or secondary syphilis.'
Of our 1800 patients, 334 (18.6%), had previously been treated for syphilis,' which may account for the differences seen between our study and others.
Of considerable concern are reports of apparent treatment failure after adequate doses of benzathine penicillin had been given to patients with secondary syphilis and coexisting HIV infection.'8 '9 The natural history of syphilis may alter in patients with HIV infection,' though one study has shown no difference in the serological response to syphilis in men with and without HIV infection.2' Patients infected with HIV who develop syphilis need careful evaluation and follow up.
In summary, we have reviewed the diagnosis, treatment, and serological response to treatment in patients attending a central London STD clinic with primary or secondary syphilis during a 20 year period. We have highlighted the importance ofdark ground evaluation in all patients suspected ofhaving primary syphilis, the fact that a small percentage ofpatients with secondary syphilis may give negative results to serology tests at presentation, and finally that a sizeable minority of patients have persistently positive VDRL test results after successful treatment.
